YOLFTbeta
Neuroone Medical Technologies Corp

Neuroone Medical Technologies Corp

NMTC · NASDAQ · Healthcare / Medical Devices

0.7451USD-0.00 (-0.31%)

Price History

Full chart

Market Stats

Previous Close0.7474
Open0.77
Day Range0.745 – 0.77
52-Week Range1.28 – 6.96
Volume18.07K
Market Cap11.84M
P/E (TTM)0.00
Forward P/E0.00
EPS-0.95
Dividend Yield0.00%
Beta0.64
50-Day Avg1.70
200-Day Avg3.64

About

NeuroOne Medical Technologies Corporation, a medical technology company, provides solutions for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording in the United States. The company also provides solutions for spinal cord stimulation, brain stimulation, drug delivery and ablation solutions for patients suffering from epilepsy, trigeminal neuralgia, Parkinson's disease, dystonia, essential tremors, and chronic pain due to failed back surgeries and other pain-related neurological disorders. The company has a collaboration with the Department of Neurology's Division of Epilepsy at the University of Minnesota Medical School to advance a study evaluating epilepsy therapies. The company is based in Eden Prairie, Minnesota.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOMr. David A. Rosa M.D.
  • Employees18
  • Headquarters7599 Anagram Drive, Eden Prairie, MN, United States, 55344, USA
  • Websitehttps://nmtc1.com

Leadership

  • Mr. David A. Rosa M.D.President, CEO & Director · b. 1964
  • Mr. Christopher R. Volker CFAChief Financial Officer
  • Mr. Ronald W. McClurgSenior Advisor · b. 1958
  • Mr. Mark ChristiansonCo-Founder, Business Development Director & Medical Sales Liaison · b. 1967
  • Mr. Steven MertensChief Technology Officer · b. 1963
  • Ms. Emily JohnsChief Administrative Officer & General Counsel · b. 1991
  • Mr. Hijaz HarisVice President of Marketing
  • Dr. Parag G. Patil M.D., Ph.D.Chief Medical Advisor
  • Mr. David J. WambeckeChief Business Officer · b. 1984

Financials

Income Statement

Currency: USD2010-09-302011-09-302012-09-302013-09-302014-09-302015-09-302016-09-302017-09-302018-09-302019-09-302020-09-302021-09-302022-09-302023-09-302024-09-302025-09-30
Total Revenue1.17K5.40K9219211.25K7737420001.93M178.15K171.17K1.95M3.45M12.10M
Growth (%)-+362.55%-82.94%0.00%+35.61%-38.11%-4.01%-100.00%----90.75%-3.92%+1040.65%+76.86%+250.35%
Cost of Revenue-2.14K---007.74K21.67K27.57K70.55K275.89K241.96K1.50M2.37M3.96M
Gross Profit1.17K3.26K9219211.25K773742-7.74K-21.67K-27.57K1.86M-97.75K-70.79K456.52K1.08M8.14M
Gross Margin100.00%60.39%100.00%100.00%100.00%100.00%100.00%---96.34%-54.87%-41.36%23.38%31.27%67.30%
Operating Expense7.21K30.69K14.65K14.65K20.88K36.69K31.66K24.87K3.19M5.79M6.76M10.12M9.96M12.41M12.97M12.37M
Operating Income-6.04K-27.43K-13.73K-13.73K-19.63K-35.91K-30.91K-32.61K-3.21M-5.81M-4.90M-10.22M-10.03M-11.96M-11.89M-4.23M
Operating Margin-517.91%-508.11%-1491.10%-1491.10%-1571.82%-4646.05%-4166.44%----254.46%-5735.86%-5860.15%-612.32%-344.26%-34.94%
EBITDA-6.04K-27.43K--13.73K-19.63K-35.58K-30.91K-14.98K-4.15M-5.79M-4.85M-9.80M-9.88M-11.66M-11.84M-3.01M
EBITDA Margin-517.91%-508.11%--1491.10%-1571.82%-4603.36%-4166.44%----251.98%-5499.97%-5772.65%-597.21%-342.96%-24.88%
Net Income-6.04K-27.60K-13.96K-13.96K-30.55K-36.24K-62.86K-47.77K-6.83M-6.78M-13.64M-9.95M-10.00M-11.86M-12.32M-3.61M
Net Income Margin-517.91%-511.37%-1515.74%-1515.74%-2446.28%-4688.75%-8472.10%----708.00%-5584.28%-5841.95%-607.42%-356.74%-29.80%
R&D-----2.40K735.33K735.33K951.06K1.53M2.08M3.93M4.93M6.94M5.07M4.98M
R&D as % of Total Revenue-----310.48%99101.48%---107.75%2203.25%2879.86%355.49%146.69%41.19%
Interest Expense017602275.46K33014.02K01.40M284.56K7.52M3.05K31.15K0228.99K334.06K
Interest Expense % of Total Revenue0.00%3.26%0.00%24.65%437.23%42.69%1889.22%---390.57%1.71%18.20%0.00%6.63%2.76%

Balance Sheet

Currency: USD2009-09-302010-09-302011-09-302012-09-302013-09-302014-09-302015-09-302016-09-302017-09-302018-09-302019-09-302020-09-302021-09-302022-09-302023-09-302024-09-302025-09-30
Total Assets-9.13K13.85K1.12K1.12K6082051.84K756.93K218.72K532.62K4.76M7.94M12.82M8.10M5.37M10.79M
Total Liabilities-13.45K17.13K18.36K18.36K28.91K35.59K83.33K1.02M4.61M1.77M2.69M1.38M3.22M1.85M4.55M3.71M
Total Equity--4.32K-3.28K-17.24K-17.24K-28.30K-35.39K-81.49K-266.22K-4.40M-1.24M2.07M6.55M9.60M6.25M822.01K7.07M
Cash-9.13K13.85K1.12K1.12K608205-1.84K522.22K13.26K260.75K4.04M6.90M8.16M5.32M1.46M6.57M
Total Debt-10.00K20.00K20.00K17.00K26.50K13.62K13.62K275.20K1.68M-1.32M315.67K202.90K184.40K260.16K266.81K
Net Debt--9.13K-13.85K18.88K15.88K25.89K-20513.62K-247.02K1.66M-260.75K-2.72M-6.59M-7.96M-5.14M-1.20M-6.30M

Cash Flow

Currency: USD2009-09-302010-09-302011-09-302012-09-302013-09-302014-09-302015-09-302016-09-302017-09-302018-09-302019-09-302020-09-302021-09-302022-09-302023-09-302024-09-302025-09-30
Operating Cash Flow6.18K-5.09K-27.43K-13.73K-13.73K-25.09K-26.17K-30.23K-21.11K-2.83M-5.40M-3.43M-8.60M-7.52M-12.89M-11.01M-2.84M
Investing Cash Flow-------91.71K-91.71K-91.71K-146.71K-123.35K-122.43K-67.08K-3.24M2.65M-120.20K-81.74K
Financing Cash Flow-13.00K32.15K1.00K1.00K24.50K25.85K30.02K21.11K2.92M5.77M7.32M11.53M12.02M7.40M7.27M8.03M
Capital Expenditure000000058.35K91.71K91.71K123.35K122.43K67.08K275.23K384.12K120.20K81.74K
Free Cash Flow6.18K-5.09K-27.43K-13.73K-13.73K-25.09K-26.17K-30.23K-21.11K-2.83M-5.52M-3.55M-8.67M-7.79M-13.27M-11.13M-2.92M
Dividends Paid------0000-------
FCF to OCF100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%102.29%103.57%100.78%103.66%102.98%101.09%102.88%
Dividend Paid to FCF------0.00%0.00%0.00%0.00%-------

Earnings

Report DateDec 31, 2016Mar 31, 2017Jun 30, 2017Sep 30, 2017Dec 31, 2017Mar 31, 2018May 16, 2018Aug 13, 2018Dec 12, 2018Feb 14, 2019May 10, 2019Aug 14, 2019Dec 20, 2019Feb 14, 2020May 14, 2020Aug 13, 2020Dec 8, 2020Feb 16, 2021May 14, 2021Aug 13, 2021Dec 15, 2021Feb 14, 2022May 12, 2022Aug 11, 2022Dec 22, 2022Feb 13, 2023May 12, 2023Aug 14, 2023Dec 14, 2023Feb 13, 2024May 14, 2024Aug 14, 2024Dec 12, 2024Feb 12, 2025May 13, 2025Aug 14, 2025Dec 16, 2025Feb 17, 2026May 12, 2026Aug 13, 2026
EPS Estimate0.000.000.000.00-----------0.00----0.25-0.22-1.14-1.20-1.35-0.11-0.66-1.23-1.23-0.17-0.84-0.10-0.09-0.09-0.60-0.54-0.30-0.06-0.24-0.23-0.22
EPS Actual-0.14-0.42-0.66-0.56-0.63-0.52-0.17-0.16-0.25-0.14-0.20-0.14-0.10-0.34-0.10-0.44-0.03-0.09-0.64-0.25-0.22-1.08-1.14-1.02-0.09-0.66-1.26-1.20-0.13-0.84-0.11-0.10-0.110.36-0.42-0.18-0.03-0.18-0.25-0.28
Surprise-------------------0.00%0.00%5.26%5.00%24.44%18.18%0.00%-2.44%2.44%23.53%0.00%-10.20%-12.44%-24.44%160.00%22.22%40.00%46.00%25.00%-8.43%-27.27%
Timing----------------After-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-market-Pre-market

Key Statistics & Ratios

Market Cap11.84M
Enterprise Value10.38M
Trailing P/E0.00
Forward P/E0.00
Price / Sales0.95
Price / Book3.25
EPS-0.95
Book Value0.433
Revenue (TTM)12.47M
Gross Profit (TTM)2.87M
EBITDA-7.66M
Profit Margin-59.71%
Operating Margin-122.87%
Return on Equity-124.66%
Return on Assets-58.07%
Shares Outstanding9.11M
Shares Float6.24M
Beta0.64
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Analyst Ratings

Strong Buy
Based on 1 analystsTarget 7.27
  • Strong Buy
    1

Ownership Breakdown

Institutions
22.45%
Insiders
25.60%
Retail / Other
51.95%

Top Institutional Holders

  • Bleichroeder LP
    4.00M7.32%
  • Bard Associates Inc
    305.43K3.35%
  • Vanguard Capital Management, LLC
    1.40M2.56%
  • Renaissance Technologies Corp
    655.45K1.20%
  • Geode Capital Management, LLC
    615.61K1.13%
  • Sio Capital Management, LLC
    82.77K0.91%
  • Vanguard Fiduciary Trust Co
    292.08K0.53%
  • Essex Investment Management Company, LLC
    43.58K0.48%
  • CAMBRIDGE Invest RESEARCH ADVISORS, INC.
    171.00K0.31%
  • Northern Trust Corp
    112.12K0.21%
  • Citadel Advisors Llc
    15.03K0.17%
  • Belpointe Asset Management LLC
    12.50K0.14%
  • Legato Capital Management LLC
    10.27K0.11%
  • State Street Corp
    59.50K0.11%

Top Fund Holders

  • Vanguard MStar Total Stk Mkt Idx Invest
    254.94K2.80%
  • Fidelity Extended Market Index
    45.05K0.49%
  • iShares Micro-Cap ETF
    23.49K0.26%
  • Fidelity Total Market Index
    13.91K0.15%
  • Fidelity Series Total Market Index
    11.88K0.13%
  • Vanguard Balanced Index Inv
    7.72K0.08%

Stock Splits

  • Apr 16, 20261:6
  • Apr 1, 20211:3